+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Cilazapril Market by Formulation (Cilazapril Hydrochloride, Cilazapril Monohydrate), Form (Capsules, Tablets), Application, Distribution Channel - Forecast 2024-2030

  • PDF Icon

    Report

  • 184 Pages
  • June 2024
  • Region: Global
  • 360iResearch™
  • ID: 5977785
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Cilazapril Market grew from USD 240.02 million in 2023 to USD 251.57 million in 2024. It is expected to continue growing at a CAGR of 5.07%, reaching USD 339.38 million by 2030.

By dilating the blood vessels, cilazapril helps to reduce blood pressure and reduce the workload on the heart, thus preventing strokes, heart attacks, and kidney problems. Its importance lies in its efficacy and ability to manage these cardiovascular conditions, helping patients maintain a better quality of life. Cilazapril supports long-term health outcomes by curbing the progression of potentially life-threatening conditions as a vital component in cardiovascular disease management. The global market for cilazapril is primarily driven by the rising number of individuals diagnosed with hypertension and other heart-related conditions. Cilazapril, as an ACE inhibitor, is crucial in managing high blood pressure, thereby preventing potential cardiovascular complications. This increasing patient base is a significant growth factor as it directly correlates with the heightened demand for effective treatment options. However, strict government regulations and cases of product recalls associated with cilazapril are significant challenges faced by the manufacturers. Moreover, continuous investment and focus on research and development can lead to innovative formulations of cilazapril that offer improved efficacy or reduced side effects. Such advancements can enhance patient outcomes and adherence to treatment regimens, expanding the drug's marketability and patient acceptance.

Regional Insights

In America, particularly in the United States and Canada, the demand for cilazapril closely follows the prevalence of hypertension and cardiovascular diseases. Both countries have well-established healthcare systems and a high awareness of chronic disease management. However, patient preferential factors and rigorous regulatory standards influence cilazapril's market dynamics. The United States sees frequent updates in treatment guidelines by organizations such as the American Heart Association (AHA), which can affect cilazapril usage. In the European Union, a well-coordinated approach to healthcare and universal health coverage in many countries leads to a steady demand for cilazapril. The European Medicines Agency (EMA) regulates the market, ensuring a high standard of patient safety. Recent investments have focused on cardiovascular research, which has directly impacted cilazapril's usage and development. The Middle East and Africa, however, present a contrasting scenario. While some Gulf nations with high healthcare spending show potential for market growth, parts of Africa need more healthcare infrastructure and affordability issues. Moreover, Asia Pacific is a diverse region with varying healthcare access and economic levels. In countries including Japan, an aging population has heightened the need for effective hypertension management solutions, making Japan a significant market for cilazapril. Advanced healthcare infrastructure and local guidelines strongly influence cilazapril use here. China and India, with their massive populations, are witnessing a surge in chronic diseases due to lifestyle changes. China's recent healthcare reforms and India's growing healthcare expenditure indicate potential market growth. Investments are mainly directed towards expanding healthcare access and awareness programs, which could increase cilazapril adoption.

Market Insights

Market Dynamics

  • The market dynamics represent an ever-changing landscape of the Cilazapril Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers

  • Increasing prevalence of hypertension and heart conditions
  • Growing geriatric population across countries

Market Restraints

  • Product recall and side effects associated with cilazapril

Market Opportunities

  • Enhanced funding and infrastructure improvements in healthcare
  • Combination therapies to enhance drug efficacy

Market Challenges

  • Availability of alternative treatments

Market Segmentation Analysis

  • Formulation: Extensive usage of cilazapril hydrochloride formulation to enhance medication’s solubility and stability
  • Application: Expanding consumption of cilazapril drugs to lower high blood pressure, prevent heart attacks, and kidney problems

Industry Insights

  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Cilazapril Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Cilazapril Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Lupin Secures USFDA Approval for Generic Cilazapril

Lupin announced its achievement of receiving approval from the US Food and Drug Administration (USFDA) to market its generic version of the hypertension medication, Cilazapril. This authorization enables Lupin to offer a cost-effective alternative to the brand-name drug, primarily prescribed for treating high blood pressure. This development marks a significant milestone for Lupin and enhances its portfolio in the competitive generic drug market, potentially improving access to affordable healthcare options for patients managing hypertension in the United States.

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Cilazapril Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Cilazapril Market, highlighting leading vendors and their innovative profiles. These include Adooq Bioscience LLC, ANGLE BIO PHARMA, ApexBio Technology, Biorbyt Ltd., Biosynth Ltd., Cayman Chemical, Chemicea Limited, Enomark, He Ako Hiringa, Hetero Labs Limited, LGM Pharma, Manus Aktteva Biopharma LLP, Merck KGaA, MIMS Pte Ltd., and Santa Cruz Biotechnology, Inc..

Market Segmentation & Coverage

This research report categorizes the Cilazapril Market to forecast the revenues and analyze trends in each of the following sub-markets:

Formulation

  • Cilazapril Hydrochloride
  • Cilazapril Monohydrate

Form

  • Capsules
  • Tablets

Application

  • Heart Failure Management
  • Hypertension Management

Distribution Channel

  • Hospital Pharmacies
  • Offline Retail Pharmacies
  • Online Pharmacies

Region

Americas

  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
  • California
  • Florida
  • Illinois
  • New York
  • Ohio
  • Pennsylvania
  • Texas

Asia-Pacific

  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
  • Vietnam

Europe, Middle East & Africa

  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Purchase of this report includes 1 year online access with quarterly updates

Purchase of this report includes 1 year online access with quarterly updates

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of hypertension and heart conditions
5.1.1.2. Growing geriatric population across countries
5.1.2. Restraints
5.1.2.1. Product recall and side effects associated with cilazapril
5.1.3. Opportunities
5.1.3.1. Enhanced funding and infrastructure improvements in healthcare
5.1.3.2. Combination therapies to enhance drug efficacy
5.1.4. Challenges
5.1.4.1. Availability of alternative treatments
5.2. Market Segmentation Analysis
5.2.1. Formulation: Extensive usage of cilazapril hydrochloride formulation to enhance medication’s solubility and stability
5.2.2. Application: Expanding consumption of cilazapril drugs to lower high blood pressure, prevent heart attacks, and kidney problems
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis
6. Cilazapril Market, by Formulation
6.1. Introduction
6.2. Cilazapril Hydrochloride
6.3. Cilazapril Monohydrate
7. Cilazapril Market, by Form
7.1. Introduction
7.2. Capsules
7.3. Tablets
8. Cilazapril Market, by Application
8.1. Introduction
8.2. Heart Failure Management
8.3. Hypertension Management
9. Cilazapril Market, by Distribution Channel
9.1. Introduction
9.2. Hospital Pharmacies
9.3. Offline Retail Pharmacies
9.4. Online Pharmacies
10. Americas Cilazapril Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Cilazapril Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Cilazapril Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.3.1. Lupin Secures USFDA Approval for Generic Cilazapril
13.4. Strategy Analysis & Recommendation
14. Competitive Portfolio
14.1. Key Company Profiles
14.2. Key Product Portfolio
List of Figures
FIGURE 1. CILAZAPRIL MARKET RESEARCH PROCESS
FIGURE 2. CILAZAPRIL MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL CILAZAPRIL MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL CILAZAPRIL MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL CILAZAPRIL MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. CILAZAPRIL MARKET DYNAMICS
FIGURE 7. GLOBAL CILAZAPRIL MARKET SIZE, BY FORMULATION, 2023 VS 2030 (%)
FIGURE 8. GLOBAL CILAZAPRIL MARKET SIZE, BY FORMULATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CILAZAPRIL MARKET SIZE, BY FORM, 2023 VS 2030 (%)
FIGURE 10. GLOBAL CILAZAPRIL MARKET SIZE, BY FORM, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CILAZAPRIL MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 12. GLOBAL CILAZAPRIL MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 14. GLOBAL CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS CILAZAPRIL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS CILAZAPRIL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES CILAZAPRIL MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES CILAZAPRIL MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC CILAZAPRIL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC CILAZAPRIL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CILAZAPRIL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CILAZAPRIL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. CILAZAPRIL MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 24. CILAZAPRIL MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. CILAZAPRIL MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL CILAZAPRIL MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL CILAZAPRIL MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL CILAZAPRIL MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL CILAZAPRIL MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL CILAZAPRIL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL CILAZAPRIL MARKET SIZE, BY CILAZAPRIL HYDROCHLORIDE, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL CILAZAPRIL MARKET SIZE, BY CILAZAPRIL HYDROCHLORIDE, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL CILAZAPRIL MARKET SIZE, BY CILAZAPRIL MONOHYDRATE, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL CILAZAPRIL MARKET SIZE, BY CILAZAPRIL MONOHYDRATE, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL CILAZAPRIL MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL CILAZAPRIL MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL CILAZAPRIL MARKET SIZE, BY CAPSULES, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL CILAZAPRIL MARKET SIZE, BY CAPSULES, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL CILAZAPRIL MARKET SIZE, BY TABLETS, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL CILAZAPRIL MARKET SIZE, BY TABLETS, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL CILAZAPRIL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL CILAZAPRIL MARKET SIZE, BY HEART FAILURE MANAGEMENT, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL CILAZAPRIL MARKET SIZE, BY HEART FAILURE MANAGEMENT, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL CILAZAPRIL MARKET SIZE, BY HYPERTENSION MANAGEMENT, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL CILAZAPRIL MARKET SIZE, BY HYPERTENSION MANAGEMENT, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL CILAZAPRIL MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL CILAZAPRIL MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL CILAZAPRIL MARKET SIZE, BY OFFLINE RETAIL PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL CILAZAPRIL MARKET SIZE, BY OFFLINE RETAIL PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL CILAZAPRIL MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL CILAZAPRIL MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 33. AMERICAS CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 34. AMERICAS CILAZAPRIL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 35. AMERICAS CILAZAPRIL MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 36. AMERICAS CILAZAPRIL MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 37. AMERICAS CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 38. AMERICAS CILAZAPRIL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 39. AMERICAS CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 40. AMERICAS CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 41. AMERICAS CILAZAPRIL MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 42. AMERICAS CILAZAPRIL MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 43. ARGENTINA CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 44. ARGENTINA CILAZAPRIL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 45. ARGENTINA CILAZAPRIL MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 46. ARGENTINA CILAZAPRIL MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 47. ARGENTINA CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 48. ARGENTINA CILAZAPRIL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 49. ARGENTINA CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 50. ARGENTINA CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 51. BRAZIL CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 52. BRAZIL CILAZAPRIL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 53. BRAZIL CILAZAPRIL MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 54. BRAZIL CILAZAPRIL MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 55. BRAZIL CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 56. BRAZIL CILAZAPRIL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 57. BRAZIL CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 58. BRAZIL CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 59. CANADA CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 60. CANADA CILAZAPRIL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 61. CANADA CILAZAPRIL MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 62. CANADA CILAZAPRIL MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 63. CANADA CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 64. CANADA CILAZAPRIL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 65. CANADA CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 66. CANADA CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 67. MEXICO CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 68. MEXICO CILAZAPRIL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 69. MEXICO CILAZAPRIL MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 70. MEXICO CILAZAPRIL MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 71. MEXICO CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 72. MEXICO CILAZAPRIL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 73. MEXICO CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 74. MEXICO CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 75. UNITED STATES CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 76. UNITED STATES CILAZAPRIL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 77. UNITED STATES CILAZAPRIL MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 78. UNITED STATES CILAZAPRIL MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 79. UNITED STATES CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 80. UNITED STATES CILAZAPRIL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 81. UNITED STATES CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 82. UNITED STATES CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 83. UNITED STATES CILAZAPRIL MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 84. UNITED STATES CILAZAPRIL MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 85. ASIA-PACIFIC CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 86. ASIA-PACIFIC CILAZAPRIL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 87. ASIA-PACIFIC CILAZAPRIL MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 88. ASIA-PACIFIC CILAZAPRIL MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 89. ASIA-PACIFIC CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 90. ASIA-PACIFIC CILAZAPRIL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 91. ASIA-PACIFIC CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 92. ASIA-PACIFIC CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 93. ASIA-PACIFIC CILAZAPRIL MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 94. ASIA-PACIFIC CILAZAPRIL MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 95. AUSTRALIA CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 96. AUSTRALIA CILAZAPRIL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 97. AUSTRALIA CILAZAPRIL MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 98. AUSTRALIA CILAZAPRIL MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 99. AUSTRALIA CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 100. AUSTRALIA CILAZAPRIL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 101. AUSTRALIA CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 102. AUSTRALIA CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 103. CHINA CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 104. CHINA CILAZAPRIL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 105. CHINA CILAZAPRIL MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 106. CHINA CILAZAPRIL MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 107. CHINA CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 108. CHINA CILAZAPRIL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 109. CHINA CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 110. CHINA CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 111. INDIA CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 112. INDIA CILAZAPRIL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 113. INDIA CILAZAPRIL MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 114. INDIA CILAZAPRIL MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 115. INDIA CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 116. INDIA CILAZAPRIL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 117. INDIA CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 118. INDIA CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 119. INDONESIA CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 120. INDONESIA CILAZAPRIL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 121. INDONESIA CILAZAPRIL MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 122. INDONESIA CILAZAPRIL MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 123. INDONESIA CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 124. INDONESIA CILAZAPRIL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 125. INDONESIA CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 126. INDONESIA CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 127. JAPAN CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 128. JAPAN CILAZAPRIL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 129. JAPAN CILAZAPRIL MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 130. JAPAN CILAZAPRIL MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 131. JAPAN CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 132. JAPAN CILAZAPRIL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 133. JAPAN CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 134. JAPAN CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 135. MALAYSIA CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 136. MALAYSIA CILAZAPRIL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 137. MALAYSIA CILAZAPRIL MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 138. MALAYSIA CILAZAPRIL MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 139. MALAYSIA CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 140. MALAYSIA CILAZAPRIL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 141. MALAYSIA CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 142. MALAYSIA CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 143. PHILIPPINES CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 144. PHILIPPINES CILAZAPRIL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 145. PHILIPPINES CILAZAPRIL MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 146. PHILIPPINES CILAZAPRIL MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 147. PHILIPPINES CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 148. PHILIPPINES CILAZAPRIL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 149. PHILIPPINES CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 150. PHILIPPINES CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 151. SINGAPORE CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 152. SINGAPORE CILAZAPRIL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 153. SINGAPORE CILAZAPRIL MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 154. SINGAPORE CILAZAPRIL MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 155. SINGAPORE CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 156. SINGAPORE CILAZAPRIL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 157. SINGAPORE CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 158. SINGAPORE CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 159. SOUTH KOREA CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 160. SOUTH KOREA CILAZAPRIL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 161. SOUTH KOREA CILAZAPRIL MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 162. SOUTH KOREA CILAZAPRIL MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 163. SOUTH KOREA CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 164. SOUTH KOREA CILAZAPRIL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 165. SOUTH KOREA CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 166. SOUTH KOREA CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 167. TAIWAN CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 168. TAIWAN CILAZAPRIL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 169. TAIWAN CILAZAPRIL MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 170. TAIWAN CILAZAPRIL MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 171. TAIWAN CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 172. TAIWAN CILAZAPRIL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 173. TAIWAN CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 174. TAIWAN CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 175. THAILAND CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 176. THAILAND CILAZAPRIL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 177. THAILAND CILAZAPRIL MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 178. THAILAND CILAZAPRIL MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 179. THAILAND CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 180. THAILAND CILAZAPRIL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 181. THAILAND CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 182. THAILAND CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 183. VIETNAM CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 184. VIETNAM CILAZAPRIL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 185. VIETNAM CILAZAPRIL MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 186. VIETNAM CILAZAPRIL MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 187. VIETNAM CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 188. VIETNAM CILAZAPRIL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 189. VIETNAM CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 190. VIETNAM CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA CILAZAPRIL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA CILAZAPRIL MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA CILAZAPRIL MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA CILAZAPRIL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA CILAZAPRIL MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA CILAZAPRIL MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 201. DENMARK CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 202. DENMARK CILAZAPRIL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 203. DENMARK CILAZAPRIL MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 204. DENMARK CILAZAPRIL MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 205. DENMARK CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 206. DENMARK CILAZAPRIL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 207. DENMARK CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 208. DENMARK CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 209. EGYPT CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 210. EGYPT CILAZAPRIL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 211. EGYPT CILAZAPRIL MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 212. EGYPT CILAZAPRIL MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 213. EGYPT CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 214. EGYPT CILAZAPRIL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 215. EGYPT CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 216. EGYPT CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 217. FINLAND CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 218. FINLAND CILAZAPRIL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 219. FINLAND CILAZAPRIL MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 220. FINLAND CILAZAPRIL MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 221. FINLAND CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 222. FINLAND CILAZAPRIL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 223. FINLAND CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 224. FINLAND CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 225. FRANCE CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 226. FRANCE CILAZAPRIL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 227. FRANCE CILAZAPRIL MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 228. FRANCE CILAZAPRIL MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 229. FRANCE CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 230. FRANCE CILAZAPRIL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 231. FRANCE CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 232. FRANCE CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 233. GERMANY CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 234. GERMANY CILAZAPRIL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 235. GERMANY CILAZAPRIL MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 236. GERMANY CILAZAPRIL MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 237. GERMANY CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 238. GERMANY CILAZAPRIL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 239. GERMANY CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 240. GERMANY CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 241. ISRAEL CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 242. ISRAEL CILAZAPRIL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 243. ISRAEL CILAZAPRIL MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 244. ISRAEL CILAZAPRIL MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 245. ISRAEL CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 246. ISRAEL CILAZAPRIL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 247. ISRAEL CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 248. ISRAEL CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 249. ITALY CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 250. ITALY CILAZAPRIL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 251. ITALY CILAZAPRIL MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 252. ITALY CILAZAPRIL MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 253. ITALY CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 254. ITALY CILAZAPRIL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 255. ITALY CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 256. ITALY CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 257. NETHERLANDS CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 258. NETHERLANDS CILAZAPRIL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 259. NETHERLANDS CILAZAPRIL MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 260. NETHERLANDS CILAZAPRIL MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 261. NETHERLANDS CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 262. NETHERLANDS CILAZAPRIL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 263. NETHERLANDS CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 264. NETHERLANDS CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 265. NIGERIA CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 266. NIGERIA CILAZAPRIL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 267. NIGERIA CILAZAPRIL MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 268. NIGERIA CILAZAPRIL MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 269. NIGERIA CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 270. NIGERIA CILAZAPRIL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 271. NIGERIA CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 272. NIGERIA CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 273. NORWAY CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 274. NORWAY CILAZAPRIL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 275. NORWAY CILAZAPRIL MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 276. NORWAY CILAZAPRIL MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 277. NORWAY CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 278. NORWAY CILAZAPRIL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 279. NORWAY CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 280. NORWAY CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 281. POLAND CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 282. POLAND CILAZAPRIL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 283. POLAND CILAZAPRIL MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 284. POLAND CILAZAPRIL MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 285. POLAND CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 286. POLAND CILAZAPRIL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 287. POLAND CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 288. POLAND CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 289. QATAR CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 290. QATAR CILAZAPRIL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 291. QATAR CILAZAPRIL MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 292. QATAR CILAZAPRIL MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 293. QATAR CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 294. QATAR CILAZAPRIL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 295. QATAR CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 296. QATAR CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 297. RUSSIA CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 298. RUSSIA CILAZAPRIL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 299. RUSSIA CILAZAPRIL MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 300. RUSSIA CILAZAPRIL MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 301. RUSSIA CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 302. RUSSIA CILAZAPRIL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 303. RUSSIA CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 304. RUSSIA CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 305. SAUDI ARABIA CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 306. SAUDI ARABIA CILAZAPRIL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 307. SAUDI ARABIA CILAZAPRIL MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 308. SAUDI ARABIA CILAZAPRIL MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 309. SAUDI ARABIA CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 310. SAUDI ARABIA CILAZAPRIL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 311. SAUDI ARABIA CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 312. SAUDI ARABIA CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 313. SOUTH AFRICA CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 314. SOUTH AFRICA CILAZAPRIL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 315. SOUTH AFRICA CILAZAPRIL MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 316. SOUTH AFRICA CILAZAPRIL MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 317. SOUTH AFRICA CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 318. SOUTH AFRICA CILAZAPRIL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 319. SOUTH AFRICA CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 320. SOUTH AFRICA CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 321. SPAIN CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 322. SPAIN CILAZAPRIL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 323. SPAIN CILAZAPRIL MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 324. SPAIN CILAZAPRIL MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 325. SPAIN CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 326. SPAIN CILAZAPRIL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 327. SPAIN CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 328. SPAIN CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 329. SWEDEN CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 330. SWEDEN CILAZAPRIL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 331. SWEDEN CILAZAPRIL MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 332. SWEDEN CILAZAPRIL MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 333. SWEDEN CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 334. SWEDEN CILAZAPRIL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 335. SWEDEN CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 336. SWEDEN CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 337. SWITZERLAND CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 338. SWITZERLAND CILAZAPRIL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 339. SWITZERLAND CILAZAPRIL MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 340. SWITZERLAND CILAZAPRIL MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 341. SWITZERLAND CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 342. SWITZERLAND CILAZAPRIL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 343. SWITZERLAND CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 344. SWITZERLAND CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 345. TURKEY CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 346. TURKEY CILAZAPRIL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 347. TURKEY CILAZAPRIL MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 348. TURKEY CILAZAPRIL MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 349. TURKEY CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 350. TURKEY CILAZAPRIL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 351. TURKEY CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 352. TURKEY CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 353. UNITED ARAB EMIRATES CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 354. UNITED ARAB EMIRATES CILAZAPRIL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 355. UNITED ARAB EMIRATES CILAZAPRIL MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 356. UNITED ARAB EMIRATES CILAZAPRIL MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 357. UNITED ARAB EMIRATES CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 358. UNITED ARAB EMIRATES CILAZAPRIL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 359. UNITED ARAB EMIRATES CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 360. UNITED ARAB EMIRATES CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 361. UNITED KINGDOM CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 362. UNITED KINGDOM CILAZAPRIL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 363. UNITED KINGDOM CILAZAPRIL MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 364. UNITED KINGDOM CILAZAPRIL MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 365. UNITED KINGDOM CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 366. UNITED KINGDOM CILAZAPRIL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 367. UNITED KINGDOM CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 368. UNITED KINGDOM CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 369. CILAZAPRIL MARKET SHARE, BY KEY PLAYER, 2023
TABLE 370. CILAZAPRIL MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Adooq Bioscience LLC
  • ANGLE BIO PHARMA
  • ApexBio Technology
  • Biorbyt Ltd.
  • Biosynth Ltd.
  • Cayman Chemical
  • Chemicea Limited
  • Enomark
  • He Ako Hiringa
  • Hetero Labs Limited
  • LGM Pharma
  • Manus Aktteva Biopharma LLP
  • Merck KGaA
  • MIMS Pte Ltd.
  • Santa Cruz Biotechnology, Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages184
PublishedJune 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 251.57 Million
Forecasted Market Value ( USD ) by 2030 $ 339.38 Million
Compound Annual Growth Rate5.0%
Regions CoveredGlobal

Related Topics

Related Reports

Cilazapril (CAS 88768-40-5) Global Market Research Report 2024 - Product Image

Cilazapril (CAS 88768-40-5) Global Market Research Report 2024

  • Report
  • 50 Pages
  • Global
From
Global Bevantolol Market by Formulation (Intravenous Forms, Oral Tablets), Application (Angina Pectoris, Hypertension), Distribution Channel - Forecast 2024-2030 - Product Image

Global Bevantolol Market by Formulation (Intravenous Forms, Oral Tablets), Application (Angina Pectoris, Hypertension), Distribution Channel - Forecast 2024-2030

  • Report
  • 194 Pages
  • Global
From
Global Cyclandelate Market by Formulation (Injectable, Oral), Application (Cerebral Vascular Insufficiency, Peripheral Vascular Disorder), Distribution Channel - Forecast 2024-2030 - Product Image

Global Cyclandelate Market by Formulation (Injectable, Oral), Application (Cerebral Vascular Insufficiency, Peripheral Vascular Disorder), Distribution Channel - Forecast 2024-2030

  • Report
  • 194 Pages
  • Global
From
Global Anti-hypertensive Drugs Market Size, Share & Trends Analysis Report by Drug Class (Diuretics, ACE Inhibitors), Type (Primary, Secondary), Route of Administration, Distribution Channel, Region, and Segment Forecasts, 2024-2030 - Product Image

Global Anti-hypertensive Drugs Market Size, Share & Trends Analysis Report by Drug Class (Diuretics, ACE Inhibitors), Type (Primary, Secondary), Route of Administration, Distribution Channel, Region, and Segment Forecasts, 2024-2030

  • Report
  • 180 Pages
  • Global
From
Heart Transplantation Therapeutics Market Size, Share & Trends Analysis Report By Drug Type (Immunosuppressants, Anti-infectives, Analgesics), By Distribution Channel (Hospital Pharmacies), By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Heart Transplantation Therapeutics Market Size, Share & Trends Analysis Report By Drug Type (Immunosuppressants, Anti-infectives, Analgesics), By Distribution Channel (Hospital Pharmacies), By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 120 Pages
  • Global
From

About the Cilazapril Market

Cilazapril is a cardiovascular drug used to treat hypertension and congestive heart failure. It is an angiotensin-converting enzyme (ACE) inhibitor, which works by blocking the production of a hormone that causes blood vessels to narrow. This helps to reduce blood pressure and improve the flow of blood to the heart. Cilazapril is usually taken once a day, with or without food. It is available in tablet form and is usually taken in combination with other medications. Cilazapril is a widely used drug in the cardiovascular market, with many generic and branded versions available. It is often prescribed as a first-line treatment for hypertension, and is also used to treat congestive heart failure. It is generally well-tolerated, with few side effects. Some companies that produce cilazapril include Pfizer, Novartis, Merck, and Mylan. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.